Calculation of Filing Fee Tables
Form S-1
(Form Type)
Salarius Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1 - Newly Registered Securities
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price(1)(2)(3) | Fee Rate | Amount of Registration Fee |
| Fees to Be Paid | Equity | Common Stock, par value $0.0001 per share (4) | 457(o) | — | — | $6,900,000 | 0.00015310 | $1,056.39 |
| Fees to Be Paid | Equity | Pre-Funded Warrants to purchase Common Stock (4)(5) | Other | — | — | Included Above | — | — |
| Fees to Be Paid | Equity | Common Stock issuable upon exercise of Pre-Funded Warrants | 457(o) | — | — | Included Above | — | — |
| Fees to Be Paid | Equity | Representative Warrants to purchase Common Stock (5) | Other | — | — | — | — | — |
| Fees to Be Paid | Equity | Common Stock issuable upon exercise of Representative Warrants (6) | 457(o) | — | — | $1,069,500 | 0.00015310 | $163.75 |
| Total Offering Amounts | $7,969,500 | | $1,220.14 |
| Total Fees Previously Paid | — |
| Total Fee Offsets | — |
| Net Fee Due | $1,220.14 |
(1)Estimated solely for the purpose of calculating the registration fee pursuant Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).
(2)Pursuant to Rule 416(a) under the Securities Act, this registration statement shall also cover an indeterminate number of shares that may be issued and resold resulting from stock splits, stock dividends or similar transactions.
(3)Includes the price of additional shares of common stock that may be issued upon exercise of the option granted to the underwriters to cover over-allotments, if any.
(4)The proposed maximum aggregate offering price of the common stock will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering
will be reduced on a dollar-for-dollar basis based on the offering price of any common stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the common stock and pre-funded warrants (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $6,900,000.
(5)No fee pursuant to Rule 457(g) of the Securities Act.
(6)The registrant has agreed to issue upon the closing of this offering, warrants to the representative of the underwriters (the “Representative Warrants”) entitling it to purchase up to 10% of the number of shares of common stock and pre-funded warrants sold in this offering. The exercise price of the Representative Warrants is equal to 155% of the public offering price of the securities offered hereby. As estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act, the proposed maximum aggregate offering price of the Representative Warrants is $1,069,500, which is equal to 155% of $690,000 (10% of $6,900,000).
